Modulator of apoptosis-1 is a potential therapeutic target in acute ischemic injury.
Acute ischemic injury
Bax-associating protein
in vitro and in vivo stroke models
modulator of apoptosis 1
therapeutic target
Journal
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
pubmed:
23
8
2018
medline:
6
5
2020
entrez:
23
8
2018
Statut:
ppublish
Résumé
Modulator of apoptosis 1 (MOAP-1) is a Bax-associating protein highly enriched in the brain. In this study, we examined the role of MOAP-1 in promoting ischemic injuries following a stroke by investigating the consequences of MOAP-1 overexpression or deficiency in in vitro and in vivo models of ischemic stroke. MOAP-1 overexpressing SH-SY5Y cells showed significantly lower cell viability following oxygen and glucose deprivation (OGD) treatment when compared to control cells. Consistently, MOAP-1
Identifiants
pubmed: 30132384
doi: 10.1177/0271678X18794839
pmc: PMC6893981
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
Apoptosis Regulatory Proteins
0
Moap1 protein, mouse
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2406-2418Références
J Cereb Blood Flow Metab. 2018 Oct;38(10):1781-1795
pubmed: 28617078
Cell Rep. 2016 Jun 28;16(1):174-185
pubmed: 27320914
J Neuroimmunol. 2005 Dec;169(1-2):172-6
pubmed: 16214224
Cell Death Differ. 2001 Jul;8(7):679-86
pubmed: 11464212
ASN Neuro. 2015 Apr 13;7(2):null
pubmed: 25873304
J Biol Chem. 2001 Jan 26;276(4):2802-7
pubmed: 11060313
Cell Rep. 2016 Jul 26;16(4):1126-1137
pubmed: 27425622
J Cereb Blood Flow Metab. 1990 Mar;10(2):290-3
pubmed: 1689322
Nat Med. 2002 Dec;8(12):1363-8
pubmed: 12457181
J Cell Biol. 2012 Apr 30;197(3):361-7
pubmed: 22529100
Apoptosis. 2009 Apr;14(4):469-77
pubmed: 19137430
PLoS One. 2012;7(12):e51469
pubmed: 23251543
J Cereb Blood Flow Metab. 2017 Jan;37(1):291-306
pubmed: 26746864
Neural Regen Res. 2016 Jul;11(7):1108-14
pubmed: 27630694
Stroke. 2009 May;40(5):e331-9
pubmed: 19182083
Cereb Cortex. 2009 Dec;19(12):2865-79
pubmed: 19366867
Nat Rev Mol Cell Biol. 2008 Jan;9(1):47-59
pubmed: 18097445
J Neurosci. 1999 May 15;19(10):3809-17
pubmed: 10234013
Cytokine Growth Factor Rev. 1999 Jun;10(2):119-30
pubmed: 10743503
Methods Mol Biol. 2015;1254:197-210
pubmed: 25431067
Mol Cell. 2005 Jun 10;18(6):637-50
pubmed: 15949439
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10051-6
pubmed: 17535899
Nature. 2016 Jul 27;535(7613):551-5
pubmed: 27466127
Nat Rev Mol Cell Biol. 2000 Nov;1(2):120-9
pubmed: 11253364
J Cereb Blood Flow Metab. 2018 Jun;38(6):980-995
pubmed: 28685662
J Neurosci Res. 2000 Sep 15;61(6):686-92
pubmed: 10972965
Neuropharmacology. 2007 Sep;53(4):505-14
pubmed: 17692345
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14623-8
pubmed: 16199525
Neurobiol Dis. 2010 Aug;39(2):138-47
pubmed: 20359534
Stroke. 2003 Jan;34(1):207-13
pubmed: 12511776